
Safe storage and responsible disposal help protect patients from accidental poisoning and drug misuse while keeping medications stable and effective.
Breo Ellipta is indicated for long-term, once-daily, maintenance treatment of airflow obstruction and reducing exacerbations in patients with chronic obstructive pulmonary disease.
Medication Pearl of the Day: Fluticasone Furoate and Vilanterol (Breo Ellipta)
Indication: Breo Ellipta is a combination of fluticasone furoate, an inhaled corticosteroid, and vilanterol, a long-acting beta2-adrenergic agonist, indicated for long-term, once-daily, maintenance treatment of airflow obstruction and reducing exacerbations in patients with chronic obstructive pulmonary disease.
Insight:
Sources:





